Publication
An in vivo study to analyse the potential of 188Re-PEI-MP for metabolic radiotherapy of bladder carcinoma
| dc.contributor.author | Ferreira, Sara | |
| dc.contributor.author | Laranjo, Mafalda | |
| dc.contributor.author | Abrantes, Ana Margarida | |
| dc.contributor.author | Brito, Ana | |
| dc.contributor.author | Metello, Luís F. | |
| dc.contributor.author | Zeevart, Jan | |
| dc.contributor.author | Louw, Werner | |
| dc.contributor.author | Dormehl, Irene | |
| dc.contributor.author | Botelho, Maria Filomena | |
| dc.date.accessioned | 2015-07-09T15:57:52Z | |
| dc.date.available | 2015-07-09T15:57:52Z | |
| dc.date.issued | 2012 | |
| dc.description.abstract | 188Re is a promising radionuclide for metabolic therapy because of the emission of high energy beta-particles. The development of water-soluble polymers such as PEI-MP (polyethyleneimine, functionalised with methylphosphonate groups) that might be labeled with 188Re are recent approaches, with a strong potential for metabolic radiotherapy. The aim of this study was to evaluate the efficacy of 188Re-PEI-MP, as therapeutic agent for bladder carcinoma | en |
| dc.identifier.uri | http://hdl.handle.net/10400.22/6431 | |
| dc.language.iso | eng | por |
| dc.peerreviewed | yes | por |
| dc.publisher | Elsevier | por |
| dc.title | An in vivo study to analyse the potential of 188Re-PEI-MP for metabolic radiotherapy of bladder carcinoma | por |
| dc.type | other | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | S272 | por |
| oaire.citation.startPage | S272 | por |
| oaire.citation.title | European Journal of Cancer - European Association Cancer Research Congress | por |
| oaire.citation.volume | 48 | por |
| rcaap.rights | openAccess | por |
| rcaap.type | other | por |